| Net Cash Provided by (Used in) Operating Activities |
$182,789 |
USD |
55% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$50,912 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$101,376 |
USD |
-5583% |
Q3 2024 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
385,194,970 |
shares |
0.31% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$511,624 |
USD |
-2376% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,017,425 |
USD |
|
Q3 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$3,017,425 |
USD |
|
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability |
$179,019 |
USD |
-30% |
Q3 2025 |
Q1 2026 |
| Depreciation |
$38,602 |
USD |
192% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$101,376 |
USD |
|
Q3 2024 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$191,473 |
USD |
-32% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
$90,990 |
USD |
1.9% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$92,220 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$68,140 |
USD |
-25% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.07 |
pure |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$12,454 |
USD |
-54% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$92,220 |
USD |
|
Q2 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$17,789,370 |
USD |
2.2% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$500,000 |
USD |
|
Q1 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |